Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Filings indexed 1,267 across all filing types
Latest filing 2019-06-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Interim / Quarterly Report Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended March 31, 2019, pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. It contains detailed financial data on transactions with related parties, including purchases, sales, contributions to trusts, and balances receivable and payable. The document is not an announcement of a report but contains substantive financial data and analysis for a half-year period. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2019-06-14 English
Related Party Transactions
Interim / Quarterly Report Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended March 31, 2019, pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. It contains detailed financial data on transactions with related parties, including purchases, sales, contributions to trusts, and balances receivable and payable. The document is not an announcement of a report but contains substantive financial data for a half-year period. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H2 2019
2019-06-13 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 36(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to share certificates. The content is an official notification about a shareholder's lost share certificates and does not contain financial data, earnings, management changes, or other report types. It is a regulatory announcement related to shareholding but not a major shareholding notification or director dealing. Given the nature of the document as a regulatory disclosure about share certificates, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal notification rather than a report or announcement of a report publication.
2019-06-07 English
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period ....
Regulatory Filings Classification · 95% confidence The document is titled 'Secretarial Compliance Report' for the year ended March 31, 2019, prepared by a Practising Company Secretary. It references compliance with SEBI regulations and circulars, and details examination of filings and records for the financial year. The document does not contain financial statements or detailed financial analysis but is a compliance certification report. It is not an Annual Report, Interim Report, or Earnings Release. It is not a simple announcement or notice but a formal compliance report. This fits the category of Regulatory Filings (RNS), which includes compliance reports and certifications that do not fit other specific categories.
2019-05-29 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates by a shareholder. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The content is about a specific shareholder's share certificate issue and is an official notification to the exchanges. It does not contain financial data, earnings, management discussion, or any report. It is not a report publication announcement or certification. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory disclosure related to share certificate loss and replacement, which does not fit other more specific categories.
2019-05-29 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them about the loss of share certificates and the request for issuance of duplicate certificates. It references LODR Regulations 2015 and Securities Contracts (Regulation) Rules, 1957, indicating a regulatory compliance communication. The document is short (1892 characters) and does not contain financial data, management discussion, or report content. It is an official regulatory announcement related to share certificates but not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.